Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms
Background With recurrence rates after primary cytoreductive surgery (CRS) in excess of 50 per cent, repeat CRS is being performed increasingly, but survival outcomes have not been reported widely. This study examined the outcomes following repeat CRS for appendiceal cancer with peritoneal surface m...
Main Authors: | J. B. Karpes, J. D. Lansom, M. Alshahrani, R. Parikh, R. Shamavonian, N. A. Alzahrani, W. Liauw, D. L. Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2020-06-01
|
Series: | BJS Open |
Online Access: | https://doi.org/10.1002/bjs5.50262 |
Similar Items
-
Factors influencing long‐term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms
by: W. J. van Eden, et al.
Published: (2019-06-01) -
Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
by: Francesco Santullo, et al.
Published: (2021-08-01) -
Quality of Life Study following Cytoreductive Surgery and Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei including Redo Procedures
by: Rachel Kirby, et al.
Published: (2013-01-01) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases – The Hong Kong experience and literature review
by: Felix Che-lok Chow, et al.
Published: (2021-01-01) -
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
by: Kavita Murughan, et al.
Published: (2014-01-01)